Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis

par Wei, Xiaohui, Kenny, Jane R., Dickmann, Leslie, Maciuca, Romeo, Looney, Caroline, Tang, Meina T.
Publié dans J Clin Pharmacol (2016)

Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: A metabolomic study

par Crotty, Grace F., Maciuca, Romeo, Macklin, Eric A., Wang, Junhua, Montalban, Manuel, Davis, Sonnet S., Alkabsh, Jamal I., Bakshi, Rachit, Chen, Xiqun, Ascherio, Alberto, Astarita, Giuseppe, Huntwork-Rodriguez, Sarah, Schwarzschild, Michael A.
Publié dans Neurology (2020)

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE

par Kennedy, William P, Maciuca, Romeo, Wolslegel, Kristen, Tew, Wei, Abbas, Alexander R, Chaivorapol, Christina, Morimoto, Alyssa, McBride, Jacqueline M, Brunetta, Paul, Richardson, Bruce C, Davis, John C, Behrens, Timothy W, Townsend, Michael J
Publié dans Lupus Sci Med (2015)

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10

par Wang, Xiang, Negrou, Elvira, Maloney, Michael T., Bondar, Vitaliy V., Andrews, Shan V., Montalban, Manuel, Llapashtica, Ceyda, Maciuca, Romeo, Nguyen, Hoang, Solanoy, Hilda, Arguello, Annie, Przybyla, Laralynne, Moerke, Nathan J., Huntwork-Rodriguez, Sarah, Henry, Anastasia G.
Publié dans Sci Rep (2021)

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

par Hanania, Nicola A, Noonan, Michael, Corren, Jonathan, Korenblat, Phillip, Zheng, Yanan, Fischer, Saloumeh K, Cheu, Melissa, Putnam, Wendy S, Murray, Elaine, Scheerens, Heleen, Holweg, Cecile TJ, Maciuca, Romeo, Gray, Sarah, Doyle, Ramona, McClintock, Dana, Olsson, Julie, Matthews, John G, Yen, Karl
Publié dans Thorax (2015)

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

par Harris, Jeffrey M., Maciuca, Romeo, Bradley, Mary S., Cabanski, Christopher R., Scheerens, Heleen, Lim, Jeremy, Cai, Fang, Kishnani, Mona, Liao, X. Charlene, Samineni, Divya, Zhu, Rui, Cochran, Colette, Soong, Weily, Diaz, Joseph D., Perin, Patrick, Tsukayama, Miguel, Dimov, Dimo, Agache, Ioana, Kelsen, Steven G.
Publié dans Respir Res (2016)

Development of a disease progression model for leucine-rich repeat kinase 2 in Parkinson’s disease to inform clinical trial designs

par Ahamadi, Malidi, Conrado, Daniela J, Macha, Sreeraj, Sinha, Vikram, Stone, Julie, Burton, Jackson, Nicholas, Timothy, Gallagher, Jill, Dexter, David, Bani, Massimo, Boroojerdi, Babak, Smit, Hans, Weidemann, Jonas, Chen, Chao, Yang, Minhua, Maciuca, Romeo, Lawson, Rachael, Burn, David, Marek, Kenneth, Venuto, Charles, Stafford, Bob, Akalu, Mussie, Stephenson, Diane, Romero, Klaus
Publié dans Clin Pharmacol Ther (2019)